Clinical trial
Study of the Safety and Immunogenicity of an Influenza Vaccine Administered to…
NCT00264576 · Novartis Vaccines, Industry · Completed
Key facts
| NCT number | NCT00264576 |
|---|---|
| Title | Study of the Safety and Immunogenicity of an Influenza Vaccine Administered to Healthy Adults |
| Official title | A Phase 2, Observer-Blinded, Randomized, Multicenter Study in Healthy Adults to Evaluate Safety and Tolerability and to Compare Immunogenicity of a Single Dose of Either an Investigational Trivalent Inactivated Influenza Vaccine Produced in Mammalian Cell Culture or a US-licensed Trivalent… |
| Lead sponsor | Novartis Vaccines, Industry |
| Collaborators | Novartis Vaccines and Diagnostics (formerly Chiron Vaccines) |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Influenza Disease, Flu |
| Intervention type | Biological |
| Interventions | Influenza Virus Vaccine |
| Enrollment | 613 |
| Start date | Oct 1, 2005 |
| Primary completion | Dec 1, 2005 |
| Completion | May 1, 2006 |
| First posted | Dec 13, 2005 |
| Last update posted | Mar 24, 2017 |
| Countries | United States |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: